Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity
Syeda Madiha, Zehra Batool, Saiqa Tabassum, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0258928-e0258928
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action
Paolo Bellavite
Antioxidants (2023) Vol. 12, Iss. 2, pp. 280-280
Open Access | Times Cited: 79
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
María Teresa Ibarra-Gutiérrez, Norma Serrano‐García, Marisol Orozco‐Ibarra
Molecular Neurobiology (2023) Vol. 60, Iss. 4, pp. 1929-1948
Closed Access | Times Cited: 75
The Potential of Flavonoids and Flavonoid Metabolites in the Treatment of Neurodegenerative Pathology in Disorders of Cognitive Decline
James Melrose
Antioxidants (2023) Vol. 12, Iss. 3, pp. 663-663
Open Access | Times Cited: 42
Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms
Julia Anchimowicz, Piotr Zielonka, Sławomir Jakieła
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 380-380
Open Access | Times Cited: 3
Antidepressant Potential of Quercetin and its Glycoside Derivatives: A Comprehensive Review and Update
Chen Shen, Yueheng Tang, Yang Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Quercetin increases the antidepressant‐like effects of sclareol and antagonizes diazepam in thiopental sodium‐induced sleeping mice: A possible GABAergic transmission intervention
Mehedi Hasan Bappi, Md. Nayem Mia, Siddique Akber Ansari, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2198-2214
Closed Access | Times Cited: 13
Microbiota–gut–brain axis: the mediator of exercise and brain health
Piao Kang, Alan Wang
Deleted Journal (2024) Vol. 4
Open Access | Times Cited: 6
Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
Camila de Oliveira Vian, Marcelo Augusto Germani Marinho, Magno da Silva Marques, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 1, pp. 3-22
Open Access | Times Cited: 6
Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait
Ratan Das, Sudip Paul, Gajendra Kumar Mourya, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27
Role of platelet in Parkinson’s disease: Insights into pathophysiology & theranostic solutions
Samir Kumar Beura, Abhishek Panigrahi, Pooja Yadav, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101681-101681
Closed Access | Times Cited: 23
Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease
Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Esrafil Mansouri, et al.
Behavioural Brain Research (2022) Vol. 437, pp. 114100-114100
Open Access | Times Cited: 23
Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration
Giulia Magni, Benedetta Riboldi, Katia Petroni, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115257-115257
Open Access | Times Cited: 21
Neuroprotective effect of piracetam-loaded magnetic chitosan nanoparticles against thiacloprid-induced neurotoxicity in albino rats
Mohamed Abomosallam, Basma M. Hendam, Amr A. Abdallah, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 943-965
Open Access | Times Cited: 12
Neuroprotective effect of Withania somnifera leaves extract nanoemulsion against penconazole-induced neurotoxicity in albino rats via modulating TGF-β1/Smad2 signaling pathway
Mohamed Abomosallam, Basma M. Hendam, Amr A. Abdallah, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1903-1928
Open Access | Times Cited: 4
Enhanced bioavailability of Quercetin-loaded niosomal in situ gel for the management of Parkinson’s disease
Ameet V Revankar, Archana S. Patil, Reshma Karishetti, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Antiparkinsonian effects of polyphenols: A narrative review with a focus on the modulation of the gut-brain axis
Wei Zhang, Xiaoyu Dong, Rui Huang
Pharmacological Research (2023) Vol. 193, pp. 106787-106787
Open Access | Times Cited: 10
Exploitation of Quercetin’s Antioxidative Properties in Potential Alternative Therapeutic Options for Neurodegenerative Diseases
Viorica Rarinca, Mircea Nicoară, Dorel Ureche, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1418-1418
Open Access | Times Cited: 9
Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)
Sukhwinder Singh, Shivani Chib, Md Jawaid Akhtar, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 992-1015
Open Access | Times Cited: 8
Potential of tea-derived phytoconstituents against Candida albicans and C. glabrata infection
Jigisha Anand, Shubhangee Agarwal, Pavita Thapa, et al.
Elsevier eBooks (2024), pp. 621-633
Closed Access | Times Cited: 1
The Hidden Notes of Redox Balance in Neurodegenerative Diseases
Silvia Piccirillo, Simona Magi, Alessandra Preziuso, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1456-1456
Open Access | Times Cited: 7
Dopaminergic modulation by quercetin: In silico and in vivo evidence using Caenorhabditis elegans as a model
Willian Goulart Salgueiro, Marcell Valandro Soares, Cassiano Fiad Martins, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110610-110610
Closed Access | Times Cited: 3
Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
Poornima D. E. Weerasinghe-Mudiyanselage, Sohi Kang, Joong‐Sun Kim, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 560-577
Open Access | Times Cited: 5
Metabolic dysfunctions in the intranigral rotenone model of Parkinson’s disease
Ana Paula Chuproski, Evellyn M. Azevedo, Jessica L. Ilkiw, et al.
Experimental Brain Research (2023) Vol. 241, Iss. 5, pp. 1289-1298
Closed Access | Times Cited: 2
Maternal quercetin supplementation improved lipopolysaccharide-induced cognitive deficits and inflammatory response in a rat model of maternal immune activation
Hossein Abbasi, Sina Ghavami-kia, Nahid Davoodian, et al.
Toxicology and Applied Pharmacology (2024) Vol. 483, pp. 116830-116830
Closed Access
Kaempferol ameliorated levodopa-induced dyskinesia in experimental rats: A role of brain monoamines, cFOS, FosB, Parkin, Pdyn, TH, and p-JNK
PEI QIN, M Liu, Xin Wang, et al.
Biocell (2024) Vol. 48, Iss. 3, pp. 513-523
Open Access
Page 1 - Next Page

Scroll to top